Aktienanalyse zu Mobile-health Network Solutions (MNDR)MNDRMobile-health Network Solutions

Mobile-health Network Solutions is an artificial intelligence (AI)-powered digital health platform, with operations across Southeast Asia and expanding into the United States. The Company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. The Company's MaNaDr platform is a 360-degree healthcare ecosystem which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The healthcare solutions offered on its MaNaDr platform primarily encompass: MaNaDr Mobile Application, MaNaPharma, MaNaShop/MaNaStore, and MaNaCare. It offers teleconsultation services over its MaNaDr mobile application, through online consultations provided by its in-house medical team and external doctors from its network of clinic service providers. MaNaPharma includes B2B sales to clinics and other healthcare service providers. It operates in the Technology sector (PREPACKAGED SOFTWARE industry).

Currently, Mobile-health Network Solutions (MNDR) is not a strong buy due to its significant year-to-date decline of 83.49% and a negative RSI of 48.774, indicating a lack of strong momentum. Although the stock surged 24% following an acquisition announcement, it remains a penny stock with a current price of 0.94, which is only 0.7% of its 52-week high of 32.52, suggesting substantial risk. The main risk is its negative net income of -665468 reported in Q2 2026, which raises concerns about its profitability and financial stability.